HB 2613 Washington House · 2025-2026 Regular Session

Establishing safety and regulatory requirements for compounded medications.

HB 2613 establishes strict safety rules for pharmacies compounding medications in Washington, directly affecting pharmacies and compounding facilities that create custom medications (like weight loss drugs). The bill requires compounders to verify all ingredients come from FDA-registered facilities with recent inspections, obtain detailed certificates of analysis, conduct quality testing, and maintain records for two years. Violations result in fines of $1,000 per dose sold and potential loss of pharmacy licenses. The law aims to prevent unsafe ingredients - such as those from unverified foreign sources - from entering the supply chain, aligning with federal standards while adding state-level oversight.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 21, 2026 Last action Jan 30, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
1
Committee
1
Jan 30, 2026
Lower · Passed
Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
lower
1 primary · 5 co-sponsors

Sponsors